Genetic counselling on brittle grounds: recurring osteogenesis imperfecta due to parental mosaicism for a dominant mutation
- PMID: 7720740
- DOI: 10.1007/BF01991915
Genetic counselling on brittle grounds: recurring osteogenesis imperfecta due to parental mosaicism for a dominant mutation
Abstract
Osteogenesis imperfecta (OI), a dominantly inherited connective tissue disorder, is usually caused by defects in collagen I. There is growing evidence for parental mosaicism that results in affected children born to unaffected parents. This situation poses a difficult task for the geneticist because a mosaic parent may appear clinically healthy while carrying the mutation in a fraction of her or his gonadal cells. To illustrate this problem, we report a Swiss couple whose first child was affected with severe OI. The unexpected recurrence of the disorder in the second child raised the suspicion of a recessive trait or, rather, of parental mosaicism. We identified the responsible collagen mutation in the COL1A2 gene (Gly688Ser in the alpha 2(I)-chain) in both children and demonstrated the father to be a somatic mosaic for this mutation and to have subtle clinical signs such as soft skin and short stature that may be a result of his mosaic state.
Conclusion: After the birth of a child affected with OI the possibility of parental mosaicism should be considered and options for prenatal diagnosis discussed.
Comment in
-
Clinical signs of mosaicism.Eur J Pediatr. 1995 Aug;154(8):690. doi: 10.1007/BF02079086. Eur J Pediatr. 1995. PMID: 7588980 No abstract available.
Similar articles
-
Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.Hum Mutat. 1992;1(1):47-54. doi: 10.1002/humu.1380010108. Hum Mutat. 1992. PMID: 1301191
-
Recurrence of perinatal lethal osteogenesis imperfecta in sibships: parsing the risk between parental mosaicism for dominant mutations and autosomal recessive inheritance.Genet Med. 2011 Feb;13(2):125-30. doi: 10.1097/GIM.0b013e318202e0f6. Genet Med. 2011. PMID: 21239989
-
Genetic counselling and prenatal diagnosis of osteogenesis imperfecta caused by paternal mosaicism.Prenat Diagn. 1996 Nov;16(11):1032-8. doi: 10.1002/(SICI)1097-0223(199611)16:11<1032::AID-PD984>3.0.CO;2-9. Prenat Diagn. 1996. PMID: 8953637
-
Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.Acta Biochim Pol. 2002;49(2):433-41. Acta Biochim Pol. 2002. PMID: 12362985 Review.
-
Clinical screening for collagen defects in connective tissue diseases.Clin Perinatol. 1990 Dec;17(4):793-809. Clin Perinatol. 1990. PMID: 2286029 Review.
Cited by
-
[Osteogenesis imperfecta: report of a case].Pan Afr Med J. 2015 Jun 3;21:83. doi: 10.11604/pamj.2015.21.83.6416. eCollection 2015. Pan Afr Med J. 2015. PMID: 26491526 Free PMC article. French.
-
A Gly238Ser substitution in the alpha 2 chain of type I collagen results in osteogenesis imperfecta type III.Hum Genet. 1995 Feb;95(2):215-8. doi: 10.1007/BF00209405. Hum Genet. 1995. PMID: 7860070
-
Expanding the genetic and clinical spectrum of osteogenesis imperfecta: identification of novel rare pathogenic variants in type I collagen-encoding genes.Front Endocrinol (Lausanne). 2023 Oct 20;14:1254695. doi: 10.3389/fendo.2023.1254695. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37929041 Free PMC article.
-
Substitution of glycine-661 by serine in the alpha1(I) and alpha2(I) chains of type I collagen results in different clinical and biochemical phenotypes.Hum Genet. 1996 Mar;97(3):324-9. doi: 10.1007/BF02185764. Hum Genet. 1996. PMID: 8786074
-
Gonadal mosaicism and familial adenomatous polyposis.Fam Cancer. 2008;7(2):173-7. doi: 10.1007/s10689-007-9169-1. Epub 2007 Nov 18. Fam Cancer. 2008. PMID: 18026870
References
Publication types
MeSH terms
LinkOut - more resources
Medical
Molecular Biology Databases
Miscellaneous